Safety Outcomes When “Switching” Between Biosimilars and Reference Products
Biological products (biologics) play an important role in clinical care, providing safe and effective treatments for many disorders. They are a diverse category of products that include vaccines, proteins (such as insulins, monoclonal antibodies, and growth factors), as well as blood and blood products.
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
